{
  "ticker": "BMRN",
  "company_name": "BioMarin Pharmaceutical",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00935753",
      "title": "Trial of Kuvan in Lesch-Nyhan Disease",
      "status": "WITHDRAWN",
      "phase": "PHASE2, PHASE3",
      "condition": "Behavioral Manifestations of Lesch-Nyhan Disease",
      "start_date": "2009-04",
      "completion_date": "2010-02",
      "enrollment": 0,
      "sponsor": "University of California, San Diego"
    },
    {
      "nct_id": "NCT00728676",
      "title": "Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Phenylketonuria",
      "start_date": "2008-08",
      "completion_date": "2010-05",
      "enrollment": 0,
      "sponsor": "Shoji Yano"
    },
    {
      "nct_id": "NCT02401347",
      "title": "Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer",
      "start_date": "2015-08",
      "completion_date": "2022-12",
      "enrollment": 0,
      "sponsor": "Melinda Telli"
    },
    {
      "nct_id": "NCT03520712",
      "title": "Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Hemophilia A, Gene Therapy, Clotting Disorders, Blood Disorder",
      "start_date": "2018-04-24",
      "completion_date": "2024-08-07",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT00355264",
      "title": "Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Tetrahydrobiopterin Deficiencies, Hyperphenylalaninemia, Non-Phenylketonuric",
      "start_date": "2006-08",
      "completion_date": "2009-06",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT00688844",
      "title": "Nutritional and Neurotransmitter Changes in PKU Subjects on BH4",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Phenylketonuria",
      "start_date": "2008-10",
      "completion_date": "2010-10",
      "enrollment": 0,
      "sponsor": "Emory University"
    },
    {
      "nct_id": "NCT01016392",
      "title": "Observational Study on the Long Term Safety of Kuvan\u00ae Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency",
      "start_date": "2009-12",
      "completion_date": "2021-05-31",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT07073014",
      "title": "Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE3",
      "condition": "Hypochondroplasia",
      "start_date": "2025-06-20",
      "completion_date": "2040-12",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT03694353",
      "title": "Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Phenylketonuria (PKU)",
      "start_date": "2018-09-13",
      "completion_date": "2021-01-13",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT00789568",
      "title": "A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Phenylketonuria",
      "start_date": "2008-10",
      "completion_date": "2009-10",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2, PHASE3": 2,
      "": 15,
      "PHASE2": 11,
      "PHASE1, PHASE2": 4,
      "PHASE3": 9,
      "PHASE1": 6,
      "PHASE4": 2,
      "NA": 1
    },
    "by_status": {
      "WITHDRAWN": 1,
      "COMPLETED": 31,
      "TERMINATED": 9,
      "ENROLLING_BY_INVITATION": 2,
      "ACTIVE_NOT_RECRUITING": 3,
      "NO_LONGER_AVAILABLE": 1,
      "RECRUITING": 2,
      "UNKNOWN": 1
    },
    "active_trials": 7,
    "completed_trials": 31,
    "conditions": [
      "Achondroplasia",
      "Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer",
      "Autism Spectrum Disorder",
      "Autistic Disorder",
      "Behavioral Manifestations of Lesch-Nyhan Disease",
      "Childhood Solid Tumors",
      "Claudication, Intermittent, Peripheral Artery Disease, Peripheral Vascular Diseases",
      "Coronary Artery Disease",
      "Duchenne Muscular Dystrophy",
      "Endothelial Dysfunction",
      "Hemophilia A",
      "Hemophilia A, Gene Therapy, Clotting Disorders, Blood Disorder",
      "Hereditary Angioedema, HAE",
      "Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency",
      "Hypochondroplasia",
      "Intermittent Claudication",
      "Isolated Systolic Hypertension, Endothelial Dysfunction",
      "Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2, CLN2 Disease, CLN2 Disorder",
      "Late-onset Pompe Disease",
      "MPS IV A",
      "Morquio Disease, MPS - Mucopolysaccharidosis",
      "Morquio Syndrome A, Maroteaux Lamy Syndrome, MPS IVA, MPS VI",
      "Mucopolysaccharidosis IVA, Morquio A Syndrome, MPS IVA",
      "Mucopolysaccharidosis VI",
      "Muscular Dystrophies",
      "Phenylketonuria",
      "Phenylketonuria (PKU)",
      "Phenylketonuria, PKU",
      "Phenylketonurias",
      "Pompe Disease",
      "Pulmonary Arterial Hypertension",
      "Tetrahydrobiopterin Deficiencies, Hyperphenylalaninemia, Non-Phenylketonuric",
      "Tetrahydrobiopterin Deficiency"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-05T17:58:26.741119",
    "search_query": "BioMarin Pharmaceutical",
    "url": "https://clinicaltrials.gov/search?term=BioMarin+Pharmaceutical"
  }
}